Revlimid Combo Treatment Improved Survival in Newly-diagnosed Myeloma Patients in Phase 3 Trial
Newly diagnosed multiple myeloma patients unable to undergo…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
UT Southwestern Researcher Tells His CAR-T Therapy Story Ahead of Myeloma Trial
As UT Southwestern and Celgene Corporation join…
Adelson Research Foundation Supports 3-Year Myeloma Funding Initiative
The Dr. Miriam and Sheldon G. Adelson Medical…
Pomalyst Combo Delays Disease Progression in Relapsed or Refractory Myeloma Patients in Phase 3 Trial
A combination treatment including Pomalyst (pomalidomide) significantly extended the…
PT-112 Receives Orphan Drug Status for Advanced Multiple Myeloma
PT-112, an investigational small molecule that promotes cancer cell…
Most Canadians Wouldn’t Know Where to Turn If Diagnosed With Blood Cancer, Survey Finds
Some 68 percent of Canadians would feel helpless if…
